Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Nextleaf Issued Its 15th U.S. Patent, Plans to Develop IP for Psychedelic Mushroom Extraction

Nextleaf Issued Its 15th U.S. Patent, Plans to Develop IP for Psychedelic Mushroom Extraction

Nextleaf Solutions (CSE: OILS – OTCQB: OILFF) CEO Paul Pedersen joined Steve Darling from Proactive to share news the company has received another US patent. This 15th patent pertains to the extraction and purification of THC and CBD.

Pedersen also told Proactive their subsidiary Nextleaf Labs has engaged CannDelta to help with their application for a Health Canada Controlled Drugs and Substances Dealer’s Licence. This is expected to allow Nextleaf Labs to conduct a variety of activities relating to psilocybin and psilocin work including R&D.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK